Healthcare -
Biotechnology - NASDAQ - US
$ 0.47
-0.844 %
$ 27.3 M
Market Cap
-0.28
P/E
BCAB - STOCK-BASED COMPENSATION
Stock-based Compensation BCAB - BioAtla, Inc.
13.5 M
LAST VALUE
-26.57%
2 YEAR CAGR
452.24%
5 YEAR CAGR
0.00%
10 YEAR CAGR